Clinical effectiveness of routine first‐trimester combined screening for pre‐eclampsia in Spain with the addition of placental growth factor
Acta Obstetricia et Gynecologica Scandinavica · 2023
DOI: 10.1111/aogs.14687 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Acta Obstetricia et Gynecologica Scandinavica, 2023. Verfasst von Pablo Garcia-Manau und 18 weiteren Autor:innen. Beteiligte Einrichtung: Universitat Autònoma de Barcelona, Barcelona, Spain. Hauptthemen laut MEDLINE: Pre-Eclampsia, Premature Birth. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Pre‐eclampsia affects 2%–8% of pregnancies and is one of the leading causes of maternal and perinatal morbidity and mortality. First‐trimester screening using an algorithm that combines maternal characteristics, mean arterial blood pressure, uterine artery pulsatility index and biomarkers (pregnancy‐associated plasma protein‐A and placental growth factor) is the method that achieves a greater diagnostic accuracy. It has been shown that daily salicylic acid administration before 16 weeks in women at a high risk for pre‐eclampsia can reduce the incidence of preterm pre‐eclampsia. However, no previous studies have evaluated the impact of routine first‐trimester combined screening for pre‐eclampsia with placental growth factor after being implemented in the clinical practice. Material and methods This was a multicenter cohort study conducted in eight different maternities across Spain. Participants in the reference group were prospectively recruited between October 2015 and September 2017. Participants in the study group were retrospectively recruited between March 2019 and May 2021. Pre‐eclampsia risk was calculated between 11 +0 and 13 +6 weeks using the Gaussian algorithm combining maternal characteristics, mean arterial pressure, uterine arteries pulsatility index, pregnancy‐associated plasma protein‐A and placental growth factor. Patients with a risk greater than 1/170 were prescribed daily salicylic acid 150 mg until 36 weeks. Patients in the reference group did not receive salicylic acid during gestation.
Results
A significant reduction was observed in preterm pre‐eclampsia (OR 0.47; 95% CI: 0.30–0.73), early‐onset (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Universitat Autònoma de Barcelona, Barcelona, Spain.
- Department of Obstetrics, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
- Department of Obstetrics, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
- Department of Obstetrics, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
- Department of Obstetrics, Hospital Universitari Mútua Terrassa, Terrassa, Spain.
- Department of Obstetrics, Consorci Sanitari de Terrassa, Terrassa, Spain.
ORCID-Profile: Pablo Garcia-Manau, Erika Bonacina, Berta Serrano, Ester Del Barco, Manel Mendoza
Zitieren
APA
Garcia-Manau, P., Bonacina, E., Serrano, B., Caamiña, S., Ricart, M., Lopez-Quesada, E., Vives, À., Lopez, M., Pintado, E., Maroto, A., Catalan, S., Dalmau, M., Del Barco, E., Hernandez, A., Miserachs, M., San Jose, M., Armengol-Alsina, M., Carreras, E., & Mendoza, M. (2023). Clinical effectiveness of routine first‐trimester combined screening for pre‐eclampsia in Spain with the addition of placental growth factor. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.14687
Vancouver
Garcia-Manau P, Bonacina E, Serrano B, Caamiña S, Ricart M, Lopez-Quesada E, et al. Clinical effectiveness of routine first‐trimester combined screening for pre‐eclampsia in Spain with the addition of placental growth factor. Acta Obstetricia et Gynecologica Scandinavica. 2023. doi:10.1111/aogs.14687
BibTeX
@article{GarciaManau2023,
author = {Garcia-Manau, Pablo and Bonacina, Erika and Serrano, Berta and Caamiña, Sara and Ricart, Marta and Lopez-Quesada, Eva and Vives, Àngels and Lopez, Monica and Pintado, Elena and Maroto, Anna and Catalan, Sara and Dalmau, Marta and Del Barco, Ester and Hernandez, Alina and Miserachs, Marta and San Jose, Marta and Armengol-Alsina, Mireia and Carreras, Elena and Mendoza, Manel},
title = {Clinical effectiveness of routine first‐trimester combined screening for pre‐eclampsia in Spain with the addition of placental growth factor},
journal = {Acta Obstetricia et Gynecologica Scandinavica},
year = {2023},
doi = {10.1111/aogs.14687}
}
EUVIMED